Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2024-04-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
전환청구권행사 (제25회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (제25회차). This type of filing details the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure and share count. According to the provided definitions, this falls under 'Share Issue/Capital Change' (SHA), as it reports the creation of new shares through the conversion process.
2024-04-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report changes in significant share ownership or potential share ownership (such as convertible bonds) that cross reporting thresholds. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2024-04-11 Korean
전환가액의조정 (제28회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in market price. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it specifically details the adjustment of conversion price and the resulting change in the number of convertible shares, it falls under the category of Capital/Financing Update (CAP).
2024-04-08 Korean
전환가액의조정 (제25회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korean stock exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the specific changes to the conversion price, the number of convertible shares, and the underlying reasons (market price decline). This falls under capital structure changes and financing updates, specifically related to convertible securities. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most accurate category for adjustments to conversion prices of debt instruments.
2024-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM), detailing the approval of financial statements, election of directors, and other resolutions. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-03-29 Korean
[기재정정]사업보고서 (2023.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) from a Korean company, Cellumed. It contains detailed accounting policies, notes to financial statements, and regulatory filing information (indicated by the '정정신고' or amendment filing header). While it is part of a larger annual report, the content provided is a technical section detailing accounting standards and financial notes. In the context of financial reporting, this constitutes the core financial disclosure of an annual report. Given the document length and the nature of the content (detailed financial notes), it is classified as an Annual Report (10-K). FY 2023
2024-03-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.